Anticancer Tc9 cells: Long-lived tumor-killing T cells for adoptive therapy.

Oncoimmunology · 2014 · PMC4092006 · PMID 25054087

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

These findings are highly significant and crucial to achieve advances in T cell-based adoptive therapies.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.